Møller, S., Grunnet, K., Hansen, S., Schult, H., Holmberg, M., & Sorensen, M. (2012). A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy. Acta Oncologica, 51(6), 797–804. https://doi.org/10.3109/0284186X.2012.681063